ArticleVaccine2013

A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.

Fadi Saade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.